GlaxoSmithKline plc Ordinary 25p (GSK)

News, reports & tips

• Broker snap: Credit Suisse cautious about 2012 at Glaxo
  08 Feb, 2012 15:37
  Credit Suisse has trimmed its current-year forecasts for pharmaceuticals giant GlaxoSmithKline following yesterday's release of its 2011 results, with the broker saying that a "cautious 2012 outlook may disappoint".

• London close: Losses pared ahead of Greek meeting
  07 Feb, 2012 16:35
  Greek talks enter critical stage.Shareholders raise questions with terms of Glencore/Xstrata merger.Defensives in demand as investors flee from risk.

• Glaxo reports falling sales but raises divi - UPDATE
  07 Feb, 2012 11:51
  Shares in GlaxoSmithKline took a hit in afternoon trade on Tuesday after the pharmaceuticals giant reported fourth quarter sales that missed forecasts. Nevertheless, the firm upped its total dividend and…

• Friday broker round-up - UPDATE
  03 Feb, 2012 09:55
  Royal Bank of Scotland: Deutsche Bank downgrades to hold from buy.

• London close: Euro worries drag Footsie down 1.1%
  30 Jan, 2012 17:13
  Just nine stocks in the FTSE 100 finished above water on Monday as the Eurozone crisis weighed heavily on sentiment. With the borrowing rate of Portuguese debt surging, Greek talks…

• Miners sold off as dollar gains on euro crisis
  30 Jan, 2012 14:50
  The Eurozone crisis sparked a sell-off in the industrial metals and mining sector today, as ongoing talks in Greece and this afternoon's EU summit weighed on market sentiment.

• FTSE 100 movers: Banks and miners weigh footsie down
  30 Jan, 2012 13:18
  The banks were in the red as the euro crisis drags on, with Lloyds, Standard Chartered and Royal Bank of Scotland (RBS) among the worst performers. Lloyds is rumoured to…

• James Murdoch steps down from Glaxo board
  27 Jan, 2012 14:19
  James Murdoch is to step down from the board of pharmaceutical giant GlaxoSmithKline, the company announced today.

• London close: Footsie up 0.7% as banks and IAG surge
  19 Jan, 2012 17:05
  - Euro optimism drives gains.- Barclays, Lloyds, RBS leads the risers.- Essar falls 11.9%, still volatile after Indian tax ruling.

• FDA wants more data from AstraZeneca on diabetes drug
  19 Jan, 2012 07:27
  AstraZeneca says the US Food and Drug Administration (FDA) wants more clinical data on its dapagliflozin treatment for type 2 diabetes in adults.

• Miners rise on China data
  10 Jan, 2012 17:07
  Miners were posting impressive gains on Tuesday after China posted a better-than-expected trade surplus.

• FTSE 100 Movers: Miners lead index higher
  10 Jan, 2012 14:46
  Miners were leading the rise on Tuesday, with Vedanta Resources, Kazakhmys and Antofagasta gaining ground after some positive economic data from China boosted sentiment. China's trade balance widened from $145.3bn…

This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see http://www.DigitalLook.com/newsfeedterms for our terms and conditions.

© Digital Look Ltd 1998-2012. All rights reserved.

Prices delayed by at least 15 minutes.